查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2009142

镇痛药市场规模、份额、趋势和预测：按类型、药物类别、给药途径、疼痛类型、应用和地区划分（2026-2034 年）

Analgesics Market Size, Share, Trends, and Forecast by Type, Drug Class, Route of Administration, Pain Type, Application, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2025年全球镇痛药市场规模为584亿美元。展望未来，IMARC集团预测，该市场将在2026年至2034年间以3.73%的复合年增长率成长，到2034年达到812亿美元。目前，北美市场主导地位，预计2025年将占据超过32.8%的市场。推动该市场成长的主要因素包括慢性疼痛疾病盛行率的上升、全球老年人口的成长以及药物製剂技术的显着进步。此外，对非鸦片类镇痛药和非处方（OTC）镇痛药需求的成长也为该市场带来了良好的发展前景。

人口老化以及神经病变疼痛、偏头痛和关节炎等慢性疼痛疾病盛行率的上升正在推动镇痛药市场的发展。人们对疼痛管理的认识不断提高，以及对有效非处方药 (OTC) 和处方笺镇痛药的需求不断增长，都促进了市场成长。药物製剂的改进，例如合併疗法和缓释製剂，提高了患者的疗效和依从性。例如，2024 年 5 月，路易斯安那州立大学新奥尔良健康科学中心 (LSU Health New Orleans) 开发了一种新型的非成瘾性镇痛药，用于治疗急性、慢性及神经性疼痛，并在 I 期临床试验中取得了令人鼓舞的结果。这项突破性成果实现了疼痛管理，且避免了阿片类药物相关的毒性，已获得美国食品药物管理局 (FDA) 的简审类，将进行进一步的临床开发。由于对阿片类药物成瘾的担忧，非阿片类镇痛药的使用日益增多，这也进一步推动了市场的发展。

老年族群中慢性疼痛问题（例如关节炎、偏头痛和术后疼痛）的日益普遍，正在推动美国镇痛药市场的发展。疼痛管理疗法的改进也对市场扩张产生了正面影响。例如，2024年8月，Concentric Analgesics公司公布了新型疼痛管理疗法博卡辣椒素（bocacapsaicin）的令人鼓舞的数据。一项针对全膝关节置换术术和拇趾滑液囊炎切除术的II期临床试验证实，博卡辣椒素可在两週内有效缓解疼痛并促进早期停用阿片类药物，凸显了其革新术后疼痛管理的潜力。人们对疼痛管理方案的认识不断提高，以及消费者对非处方止痛药的偏好日益增强，都显着推动了市场成长。阿片类药物危机及其相关法规正在加速向非阿片类镇痛药的转变，进一步刺激了对更安全替代疗法的需求。

止痛药市场趋势

慢性病发生率增加

在全球范围内，关节炎、癌症和糖尿病等慢性疾病的日益普遍，推动了对疼痛管理解决方案的需求不断增长。根据美国疾病管制与预防中心（CDC）发布的数据，美国约有1.29亿人患有至少一种主要慢性疾病，包括心臟病、癌症、糖尿病、肥胖和高血压。此外，约42%的人口患有两种或两种以上的慢性疾病，12%的人口患有至少五种慢性疾病。随着全球人口老化，慢性疼痛疾病的发生率不断上升，因此亟需有效的止痛计画。如今，老年人更容易患上这些慢性疾病，而这些疾病往往伴随持续性疼痛。

对非鸦片类镇痛药的需求不断增长

阿片类药物危机及其高成瘾和滥用风险，促使人们越来越倾向于使用非鸦片类止痛药进行更安全的疼痛管理。非类固醇消炎剂（NSAIDs）和对乙酰胺酚等非鸦片类药物因其风险较低而日益受到欢迎。例如，2024年1月，VX-548在两项大型临床试验中显示出令人鼓舞的结果，与安慰剂相比，该药能显着减轻术后疼痛，且副作用极小。 Vertex公司计划向美国食品药物管理局（FDA）申请核准该药用于治疗中度至重度急性疼痛。这一结果为在持续的鸦片类药物危机中寻找替代成瘾性鸦片类药物的希望带来了曙光。这些解决方案对多种类型的疼痛有效，并为急性和慢性疼痛管理提供了更安全的选择。这种转变正在推动非阿片类镇痛解决方案的创新和市场成长，以满足人们对更安全治疗方法的需求。

非处方止痛药使用量增加

由于非处方止痛药易于取得且电子商务蓬勃发展，因此被广泛用作自我治疗。这些非处方药包括非类固醇消炎剂（NSAIDs）、对乙酰氨基酚及其组合药物，可方便地缓解多种症状。例如，2024年4月，Glenmark Pharmaceuticals公司获得了美国食品药物管理局（FDA）对其对乙酰胺酚乙酰胺酚和Ibuprofen片剂非专利药的核准。该公司生产的药品（Advil 2 Dual Action的非专利药）预计将透过其美国子公司Glenmark Therapeutics在美国市场销售。网路药局的扩张使得非处方止痛药更容易获得并被广泛使用。无需处方笺即可购买这些药物，有助于消费者有效、快速地控制疼痛，从而推动了非处方止痛药市场的成长。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球止痛药市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场区隔：按类型
  • 市场区隔：依药物类别划分
  • 市场区隔：依给药途径
  • 市场区隔：依疼痛类型划分
  • 市场区隔：按应用领域
  • 市场区隔：按地区
  • 市场预测

第六章 市场区隔：依类型

  • 处方笺
  • 非处方药

第七章 市场区隔：依药物类别划分

  • 阿片类药物
  • NSAID
  • 其他的

第八章 市场区隔：依给药途径

  • 口服
  • 肠外
  • 外用
  • 经皮
  • 直肠

第九章 市场区隔：依疼痛类型划分

  • 肌肉骨骼系统
  • 外科手术/创伤
  • 癌症
  • 神经病变
  • 偏头痛
  • 产科
  • 纤维肌痛
  • 烧烫伤疼痛
  • 牙科和脸部护理
  • 儿童
  • 其他的

第十章 市场区隔：依应用领域划分

  • 内部的
  • 外部的

第十一章 市场区隔：按地区划分

  • 北美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 拉丁美洲

第十二章 SWOT 分析

第十三章：价值链分析

第十四章：波特五力分析

第十五章：价格分析

  • 价格指标
  • 价格结构
  • 利润分析

第十六章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Bayer AG
    • Novartis International AG
    • GlaxoSmithKline PLC
    • Pfizer Inc.
    • Johnson & Johnson Pvt. Ltd.
    • Reckitt Benckiser（RB）Group PLC
    • Endo Pharmaceuticals PLC
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Sanofi SA
Product Code: SR112026A1138

The global analgesics market size was valued at USD 58.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 81.2 Billion by 2034, exhibiting a CAGR of 3.73% during 2026-2034. North America currently dominates the market, holding a significant market share of over 32.8% in 2025 . The market is mainly driven by the rising prevalence of chronic pain conditions, an increasing global geriatric population, and significant technological advancements in drug formulations. There is also a growing demand for non-opioid and over-the-counter (OTC) pain relievers which creates a positive outlook for the market.

The growing number of elderly people and the prevalence of chronic pain disorders such neuropathic pain, migraines, and arthritis are driving the analgesics market. Growing awareness about pain management and the demand for effective OTC and prescription pain relief solutions contribute to market growth. Improvements in medication formulations, such as combination and extended-release treatments, improve patient efficacy and compliance. For instance, in May 2024, LSU Health New Orleans developed a novel and non-addictive painkiller for acute, chronic, and neuropathic pain indicating positive outcomes in Phase 1 trials. The breakthrough addresses pain management without the toxicity associated with opioids receiving FDA Fast Track designation for further clinical development. The rising adoption of non-opioid analgesics due to concerns over opioid addiction further boosts the market.

The increased prevalence of chronic pain problems, such as arthritis, migraines, and post-surgical pain, among the elderly population is driving the analgesics market in the United States. Improvements in pain management treatments are also favorably influencing the market's expansion. For instance, in August 2024, Concentric Analgesics presented promising data on vocacapsaicin a novel pain management therapy. Phase 2 trials for total knee arthroplasty and bunionectomy showed two weeks of effective pain relief and earlier opioid cessation highlighting vocacapsaicin's potential to revolutionize postoperative pain management. Rising consumer preference for OTC pain relievers fueled by increasing awareness of pain management options significantly boosts market growth. The ongoing shift towards non-opioid analgesics due to the opioid crisis and associated regulations further accelerates demand for safer alternatives.

ANALGESICS MARKET TRENDS

Increasing Incidence of Chronic Conditions

The increasing incidence of several chronic conditions such as arthritis, cancer, and diabetes throughout the world is fueling increased demand for solutions to pain management. As estimated by the data published by the Centers for Disease Control and Prevention about 129,000,000 people in the United States suffer from at least one major chronic condition including heart disease, cancer, diabetes, obesity, and hypertension. In addition to this, approximately 42% of the total population has more than two or more chronic diseases and 12% of the population is suffering from at least five chronic diseases. As the global population ages the incidence of chronic pain conditions is on the rise which necessitates effective analgesic options. Nowadays older adults are more prone to developing these chronic conditions which often come with persistent pain.

Increasing Demand for Non-Opioid Analgesics

The opioid crisis with high addiction and abuse rates has shifted preference towards non-opioid analgesics for safer pain management. Non-opioid options like nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are increasingly popular due to their lower risk profiles. For instance, in January 2024, VX-548 demonstrated positive results in two major clinical trials showing significant pain relief after surgery compared to a placebo with few side effects. Vertex plans to seek FDA approval for the drug in treating moderate-to-severe acute pain. The results bring hope for an alternative to addictive opioid medications amidst the ongoing opioid crisis. These solutions are effective for different types of pain conditions offering a safer alternative for the management of acute and chronic pains. This shift is driving innovation and market growth in non-opioid solutions for pain relief which addresses the requirement for safer alternatives of therapy.

Rise in Use of OTC Analgesics

OTC analgesics are widely used for self-medication, as they are easily accessible, and the advent of e-commerce. These over-the-counter options which consist of NSAIDs (nonsteroidal anti-inflammatory drugs), acetaminophen, and combination products provide easy relief for many conditions. For instance, in April 2024, Glenmark Pharmaceuticals obtained USFDA approval for its generic Acetaminophen and Ibuprofen tablets. The company's drug - a generic version of Advil 2 Dual Action, will be distributed in the US market by Glenmark Therapeutics Inc, USA. OTC analgesics are widely used because it is now easy to get them due to the expansion of internet pharmacies. The availability of these drugs without a prescription helps consumers manage pain effectively and promptly, thus driving the growth of the OTC analgesics market.

ANALGESICS INDUSTRY SEGMENTATION:

Analysis by Type:

  • Prescription
  • Over the counter (OTC)

Prescription analgesics segment leads the market with around 70.0% market share in 2025. Prescription analgesics holds the largest market share because of their efficacy in relief of moderate to severe and chronic pain including postoperative pain, cancer pain, and severe arthritis. These medications including opioids and other potent pain relievers are necessary for conditions which other medications cannot effectively treat. The stringent regulation and physician supervision associated with prescription analgesics ensure appropriate use, driving their demand. Advancements in personalized medicine and targeted therapies contribute to the growth of prescription analgesics within the market.

Analysis by Drug Class:

  • Opioids
  • NSAIDs
  • Others

Opioids segment leads the market with around 52.0% market share in 2025. Opioids dominate the market share of analgesics since they remain the most effective in controlling extreme and chronic pain. The opioids include morphine, oxycodone, and fentanyl which help in managing severe pain during and after operations, such as cancer-related, and major injury pain. Despite the significant concerns over addiction and abuse, the medical necessity for potent pain relief in specific conditions ensures the continued demand for opioids. Regulatory efforts to control misuse and advancements in formulation to reduce addiction potential are shaping the market. Additionally, ongoing research into safer opioid alternatives and combination therapies further underscores the dominant position of opioids in the analgesics market.

Analysis by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Transdermal
  • Rectal

Oral leads the market with around 48.7% market share in 2025. Oral analgesics represent the leading segment in the analgesics market due to their convenience, ease of administration, and wide availability. These are in the form of tablets, capsules, and liquid and are preferred in different sorts of pains ranging from headaches to even moderate post-operative pains. This availability of over-the-counter oral solid drugs such as acetaminophen and ibuprofen plays a major role in the segment growth. Advancements in oral drug formulations such as extended-release tablets enhance patient compliance and effectiveness, further solidifying the leadership of oral analgesics in the market.

Analysis by Pain Type:

  • Musculoskeletal
  • Surgical and Trauma
  • Cancer
  • Neuropathic
  • Migraine
  • Obstetrical
  • Fibromyalgia
  • Pain due to Burns
  • Dental/Facial
  • Pediatric
  • Others

Musculoskeletal pain management exhibits a clear dominance in the analgesics market due to the high prevalence of conditions such as arthritis, back pain, and sports injuries. These conditions are widespread among the aging population and active individuals, driving significant demand for effective pain relief. Both prescription and over-the-counter analgesics are extensively used to manage musculoskeletal pain making it a critical segment within the market. The ongoing research and development in targeting specific pain pathways and improving drug formulations further bolsters this dominance. The rise in sedentary lifestyles and increasing awareness of pain management options contribute to the sustained growth of this segment.

Analysis by Application:

  • Internal
  • External

Internal application of analgesics relates to the medication taken orally as well as administered through injection within the body, which includes managing pain from the inside. Thus, it includes tablets, capsules, and liquids for internal application administration, along with intravenous and intramuscular injections. All these conditions include chronic pain, post-operative pain, and other acute severe pains. Hence, internal applications are a sizeable market segment for analgesics mainly driven by their efficiency in providing systemic pain relief.

External application of analgesics: The topical preparations in the form of creams, gels, sprays, and patches applied on the skin surface are examples of external application of analgesics. These are more effective in the treatment of localized pain conditions such as muscle strain, joint pain, and minor injuries. These have the added advantage of site-specific therapy with minimal systemic side effects. Patients prefer this for non-invasive pain management. These non-systemic treatment preferences and progress in topical drug delivery systems propel the popularity of topical applications within the analgesics market.

Regional Analysis

  • Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America

In 2025, North America accounted for the largest market share of over 32.8%. North America leads the analgesics market, accounting for the largest market share due to high healthcare expenditure, advanced medical infrastructure, and a high prevalence of chronic pain conditions. According to a report published by the Centers for Medicare & Medicaid Services, U.S. healthcare spending grew 4.1% in 2022 reaching $4.5 trillion or $13,493 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 17.3%. The region's robust regulatory environment ensures the availability of prescription as well as over-the-counter analgesics. The ongoing opioid crisis has encouraged the development and adoption of non-opioid pain relief alternatives. The presence of major pharmaceutical companies and continuous research and development activities further strengthen North America's leading position in the analgesics market.

KEY REGIONAL TAKEAWAYS:

UNITED STATES ANALGESICS MARKET ANALYSIS

In 2025, the United States captured 90.80% of revenue in the North American market. This is because more patients are suffering from chronic diseases than before, which, coupled with enhanced methods of handling pain, enhances the uptake of analgesics in the United States. Arthritis is among the common causes of chronic pain and as per the CDC it affects 58.5 million adults or 23.7% of the population, the conditions are more common in the female sex, and the aged population. In addition, growing numbers of surgeries also contribute to the increasing demand for relief from pain. The National Center for Biotechnology Information estimates approximately 310 million major surgeries that occur annually of which around 40-50 million occur in the U.S. This clearly explains the demand for effective post-surgical pain management. The opioid crisis is yet another factor ruling the market. The U.S. FDA has initiated significant efforts in February 2022 to create non-addictive opioids. This has improved the prospects for safer pain management. These regulatory initiatives are likely to enhance the demand for prescription and over-the-counter analgesics and will drive sustained growth in the market over time.

EUROPE ANALGESICS MARKET ANALYSIS

The growing elderly population in Europe is a significant factor driving increased demand for analgesics as older people are more prone to chronic pain and associated health conditions. In 2020, 21% of the European population, or 94.7 million people, were 65 years of age or older. This age group according to the European Commission constitutes a fifth of the population but represents over 62% of new cancer diagnoses at 1.7 million and 76% of cancer-related deaths at 0.98 million. This clearly indicates a growing need for effective pain management solutions particularly concerning cancer-related pain in the elderly population. Another significant driver of the need for analgesics includes neuropathic pain that affects 7-8% of the European population. Prescription and over the counter analgesics are in high demand as more patients are suffering from cancer and neuropathic pain that continues to increase. A change in demographics and growth in the burden of the conditions causing pain will continue to promote the market growth of analgesics in Europe.

ASIA PACIFIC ANALGESICS MARKET ANALYSIS

The increasing rate of incidence of cancer in Asia has been one of the reasons for driving the analgesics market in the region. In 2020, the reported cancer incidence rate was 169.1 per 100,000 people, accounting for nearly 49.3% of the global cases. Lung cancer accounted for 13.8%, breast cancer accounted for 10.8% and colorectal cancer accounted for 10.6% of the most common types in the region as per an industry report. This situation presents a significant demand for effective pain management solutions particularly given the rising rates of cancer which are predominantly observed in the elderly population.

The increasing incidence of cancer is thereby driving a higher demand for prescription as well as over-the-counter analgesics, which are significant for both acute and chronic pain management. Rising population and prevalence of cancer will continue to fuel demand for pain relief options to drive growth in the market for analgesics in the Asia-Pacific region and ensure steady market growth over the next few years.

LATIN AMERICA ANALGESICS MARKET ANALYSIS

The aging population is a key driving factor for the growing demand for analgesics in Latin America and the Caribbean. According to an industry report, 2022 recorded 88.6 million people who were 60 years of age or older hence constituting 13.4% of the overall population and this portion is projected to increase by 2030 to about 16.5%. As the elderly population grows so does the demand for pain management as the elderly are even more susceptible to chronic pain and other related health problems.

Moreover, the incidence of cancer is increasing, especially cervical cancer, raising the demand for pain relief further. The Pan American Health Organization reports that over 56,000 women have been diagnosed with cervical cancer in the region killing over 28,000. With cancer cases burgeoning, especially among the geriatric population the pressure to seek prescription or non-prescription pain relief also will continue to rise. The shifting demographic balance and rising cancer burden will provide impetus to the Latin America analgesics market going forward.

MIDDLE EAST AND AFRICA ANALGESICS MARKET ANALYSIS

One of the key factors propelling the analgesics market in the Middle East and Africa (MEA) region is the rising prevalence of osteoarthritis. The age-standardized prevalence of OA in MENA was reported to be 5,342.8 per 100,000 people in 2019 according to the National Institutes of Health (NIH). The growing need for efficient pain management options is significantly impacted by osteoarthritis, which is a common source of chronic pain in the aged population.

With an aging population in MEA and an increase in chronic conditions, the need for analgesics prescription as well as over-the-counter medications is also on the rise. Osteoarthritis causes continuous pain in the joints and leads to disability compelling people to look for relief from the condition. The above demographic trend in combination with an overall rise in chronic pain conditions is also expected to drive further demand for analgesics in the Middle East and Africa thereby facilitating further growth in the market.

COMPETITIVE LANDSCAPE:

The analgesics market is highly competitive with major pharmaceutical companies like Pfizer, Johnson & Johnson, and GlaxoSmithKline leading the industry. These companies invest heavily in research and development to introduce new and effective pain relief formulations including non-opioid alternatives and advanced drug delivery systems. For instance, in January 2024, Vertex Pharmaceuticals released positive results from two large clinical trials of its non-opioid painkiller VX-548 which significantly reduces post-surgery pain compared to a placebo. The market also sees significant competition from generic drug manufacturers which offer cost-effective alternatives to branded medications. Additionally, emerging players focusing on natural and herbal analgesics are gaining traction. Strategic collaborations, mergers and acquisitions are common as companies seek to expand their product portfolios and market reach intensifying the competitive landscape in the analgesics market.

The report provides a comprehensive analysis of the competitive landscape in the analgesics market with detailed profiles of all major companies, including:

  • Bayer AG
  • Novartis International AG
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Johnson & Johnson Pvt. Ltd.
  • Reckitt Benckiser (RB) Group PLC
  • Endo Pharmaceuticals PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Sanofi SA

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the analgesics market?

2. What is the future outlook of analgesics market?

3. What are the key factors driving the analgesics market?

4. Which region accounts for the largest analgesics market share?

5. Which are the leading companies in the global analgesics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Analgesics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Drug Class
  • 5.6 Market Breakup by Route of Administration
  • 5.7 Market Breakup by Pain Type
  • 5.8 Market Breakup by Application
  • 5.9 Market Breakup by Region
  • 5.10 Market Forecast

6 Market Breakup by Type

  • 6.1 Prescription
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Over the counter (OTC)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Opioids
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 NSAID
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Parenteral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Transdermal
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Rectal
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Pain Type

  • 9.1 Musculoskeletal
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Surgical and Trauma
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cancer
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Neuropathic
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Migraine
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Obstetrical
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7 Fibromyalgia
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast
  • 9.8 Pain due to Burns
    • 9.8.1 Market Trends
    • 9.8.2 Market Forecast
  • 9.9 Dental/Facial
    • 9.9.1 Market Trends
    • 9.9.2 Market Forecast
  • 9.10 Pediatric
    • 9.10.1 Market Trends
    • 9.10.2 Market Forecast
  • 9.11 Others
    • 9.11.1 Market Trends
    • 9.11.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Internal
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 External
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Middle East and Africa
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Latin America
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Global Analgesics Industry: SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Global Analgesics Industry: Value Chain Analysis

  • 13.1 Overview
  • 13.2 Research and Development
  • 13.3 Raw Material Procurement
  • 13.4 Manufacturing
  • 13.5 Marketing
  • 13.6 Distribution
  • 13.7 End-Use

14 Global Analgesics Industry: Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Global Analgesics Industry: Price Analysis

  • 15.1 Price Indicators
  • 15.2 Price Structure
  • 15.3 Margin Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Bayer AG
    • 16.3.2 Novartis International AG
    • 16.3.3 GlaxoSmithKline PLC
    • 16.3.4 Pfizer Inc.
    • 16.3.5 Johnson & Johnson Pvt. Ltd.
    • 16.3.6 Reckitt Benckiser (RB) Group PLC
    • 16.3.7 Endo Pharmaceuticals PLC
    • 16.3.8 Bristol-Myers Squibb Company
    • 16.3.9 Eli Lilly and Company
    • 16.3.10 Sanofi SA

List of Figures

  • Figure 1: Global: Analgesics Market: Major Drivers and Challenges
  • Figure 2: Global: Analgesics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Analgesics Market: Breakup by Type (in %), 2025
  • Figure 4: Global: Analgesics Market: Breakup by Drug Class (in %), 2025
  • Figure 5: Global: Analgesics Market: Breakup by Route of Administration (in %), 2025
  • Figure 6: Global: Analgesics Market: Breakup by Pain Type (in %), 2025
  • Figure 7: Global: Analgesics Market: Breakup by Application (in %), 2025
  • Figure 8: Global: Analgesics Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Analgesics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 10: Global: Analgesics Industry: SWOT Analysis
  • Figure 11: Global: Analgesics Industry: Value Chain Analysis
  • Figure 12: Global: Analgesics Industry: Porter's Five Forces Analysis
  • Figure 13: Global: Analgesics (Prescription) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Analgesics (Prescription) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Analgesics (Over the counter-OTC) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Analgesics (Over the counter-OTC) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Analgesics (Opioids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Analgesics (Opioids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Analgesics (NSAID) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Analgesics (NSAID) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Analgesics (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Analgesics (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Analgesics (Oral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Analgesics (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Analgesics (Parenteral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Analgesics (Parenteral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Analgesics (Topical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Analgesics (Topical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Analgesics (Transdermal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Analgesics (Transdermal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Analgesics (Rectal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Analgesics (Rectal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Analgesics (Musculoskeletal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Analgesics (Musculoskeletal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Analgesics (Surgical and Trauma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Analgesics (Surgical and Trauma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Analgesics (Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Analgesics (Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Analgesics (Neuropathic) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Analgesics (Neuropathic) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Analgesics (Migraine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Analgesics (Migraine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Analgesics (Obstetrical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Analgesics (Obstetrical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Analgesics (Fibromyalgia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Analgesics (Fibromyalgia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Analgesics (Pain due to Burns) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Analgesics (Pain due to Burns) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Global: Analgesics (Dental/Facial) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Global: Analgesics (Dental/Facial) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Global: Analgesics (Pediatric) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Global: Analgesics (Pediatric) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Global: Analgesics (Other Pain Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Global: Analgesics (Other Pain Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Global: Analgesics (Internal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Global: Analgesics (Internal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Global: Analgesics (External) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Global: Analgesics (External) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: North America: Analgesics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: North America: Analgesics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Europe: Analgesics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Europe: Analgesics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Asia Pacific: Analgesics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Asia Pacific: Analgesics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Middle East and Africa: Analgesics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Middle East and Africa: Analgesics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Latin America: Analgesics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Latin America: Analgesics Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Analgesics Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Analgesics Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Analgesics Market Forecast: Breakup by Drug Class (in Million USD), 2026-2034
  • Table 4: Global: Analgesics Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 5: Global: Analgesics Market Forecast: Breakup by Pain Type (in Million USD), 2026-2034
  • Table 6: Global: Analgesics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 7: Global: Analgesics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Analgesics Market Structure
  • Table 9: Global: Analgesics Market: Key Players